| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2858022 | 71 | F | WI | 09/10/2025 |
PNC21 TDAP |
MERCK & CO. INC. GLAXOSMITHKLINE BIOLOGICALS |
Z006889 95P4M |
Contusion, Induration, Rash, Skin warm; Contusion, Induration, Rash, Skin warm
Contusion, Induration, Rash, Skin warm; Contusion, Induration, Rash, Skin warm
|
Pt had a bruise of upper deltoid believed to be due to the Boostrix. Below the bruise was a rash tha...
Pt had a bruise of upper deltoid believed to be due to the Boostrix. Below the bruise was a rash that had been getting larger over the past few days, warm to the touch and with an area of more firm tissue below the skin.
More
|
||||||
| 2858023 | 18 | M | WA | 09/10/2025 |
COVID19 COVID19 FLU3 FLU3 |
PFIZER\BIONTECH PFIZER\BIONTECH SANOFI PASTEUR SANOFI PASTEUR |
MY9547 MY9547 U8790AA U8790AA |
Dizziness, Hyperhidrosis, Immediate post-injection reaction, Nausea, Pallor; Sen...
Dizziness, Hyperhidrosis, Immediate post-injection reaction, Nausea, Pallor; Sensory disturbance; Dizziness, Hyperhidrosis, Immediate post-injection reaction, Nausea, Pallor; Sensory disturbance
More
|
immediately after vaccinations pt started became pale and started feeling faint, nauseous, sweaty, a...
immediately after vaccinations pt started became pale and started feeling faint, nauseous, sweaty, and felt pulsing in his fingers. pt was advised to lie down with feet elevated on the wall, a cold compress was applied to the wrists and pt drank water. after several minutes of lying down pt regained color to the face, stopped sweating, and was able to go home.
More
|
||||||
| 2858024 | 72 | F | MA | 09/10/2025 |
COVID19 COVID19 FLU3 FLU3 |
MODERNA MODERNA SANOFI PASTEUR SANOFI PASTEUR |
3052036 3052036 U8764DB U8764DB |
Abdominal distension, Abdominal pain upper, Body temperature decreased, Diarrhoe...
Abdominal distension, Abdominal pain upper, Body temperature decreased, Diarrhoea, Hyperhidrosis; Nausea, Vomiting; Abdominal distension, Abdominal pain upper, Body temperature decreased, Diarrhoea, Hyperhidrosis; Nausea, Vomiting
More
|
Precisely 24 hours after vaccine, sudden onset of profuse sweating, severe stomach cramping and pain...
Precisely 24 hours after vaccine, sudden onset of profuse sweating, severe stomach cramping and pain, bloating, followed by nausea, vomiting and explosive diarrhea. There was no fever throughout the event. After 15 to 20 minutes symptoms quieted down but returned again an additional 3 times throughout the remainder of the afternoon. My temperature remained at between 96.4 and 97.6 degrees. Nausea continued throughout the night at which time I took Dramamine. The following day I was able to go to work, but felt slight nausea and continued with stomach distention and cramping.
More
|
||||||
| 2858025 | 69 | F | CA | 09/10/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Urticaria
Urticaria
|
Delayed hives all over.
Delayed hives all over.
|
||||||
| 2858026 | 62 | F | WA | 09/10/2025 |
COVID19 PNC21 |
PFIZER\BIONTECH MERCK & CO. INC. |
MY9547 Z006889 |
Pain in extremity, Pyrexia, Rash, Rash macular; Pain in extremity, Pyrexia, Rash...
Pain in extremity, Pyrexia, Rash, Rash macular; Pain in extremity, Pyrexia, Rash, Rash macular
More
|
On 9/10/25, patient called the pharmacy to report fever, arm pain and splotchy rash on arm, legs, tr...
On 9/10/25, patient called the pharmacy to report fever, arm pain and splotchy rash on arm, legs, trunk and back. She said the onset was the evening of 9/9/25. Patient advised to try cold compress, Tylenol or ibuprofen for fever and benadryl to help rash subside.
More
|
||||||
| 2858027 | 5 | M | NY | 09/10/2025 |
DTAPIPV |
SANOFI PASTEUR |
U8209CB |
Injection site induration, Injection site pain, Injection site pruritus, Injecti...
Injection site induration, Injection site pain, Injection site pruritus, Injection site warmth, Peripheral swelling
More
|
Patient woke up the following day with a swollen arm 3x the size of his other arm. His arm swelled f...
Patient woke up the following day with a swollen arm 3x the size of his other arm. His arm swelled from the shoulder down to the wrist. The injection site was firm, and extremely hot to the touch, itchy and painful. The swelling remained through the weekend into Monday and is now a week later seems to be going down but the arm is still warm to the touch.
More
|
||||||
| 2857454 | 35 | NC | 09/09/2025 |
HPV4 HPV9 HPV9 |
MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
|
Inappropriate schedule of product administration, No adverse event; Inappropriat...
Inappropriate schedule of product administration, No adverse event; Inappropriate schedule of product administration, No adverse event; Inappropriate schedule of product administration, No adverse event
More
|
No additional AE details reported; their first dose of GARDASIL (unknown if 2-, 4-, or 9- valent vac...
No additional AE details reported; their first dose of GARDASIL (unknown if 2-, 4-, or 9- valent vaccine) about 10 years ago and administered their second dose of GARDASIL 9 on 04/30/2025; This spontaneous report was received from a pharmacist, concerning to a 35-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date in 2015 (10 years ago), the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL๏ฟฝ9) or with Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL), 1 dosage form, total (route, lot# and expiration date not provided. On 30-Apr-2025, received the second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL๏ฟฝ9), 1 dosage form, total, (route, lot # and expiration date were not reported). All as prophylaxis. Since doses were administered within more than 13 months as recommended, inappropriate schedule of product administration on 30-Apr-2025. No additional AE details reported (No adverse event).
More
|
|||||||
| 2857455 | F | FL | 09/09/2025 |
COVID19 |
UNKNOWN MANUFACTURER |
|
Viral infection
Viral infection
|
The virus reactivated; This initial spontaneous safety report was reported by a Consumer or other no...
The virus reactivated; This initial spontaneous safety report was reported by a Consumer or other non-health professional and concerns an individual of unspecified age and gender who experienced the virus reactivated on an unspecified date after receiving COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) on an unspecified date. At the time of the report, the outcome of the Viral infection was Unknown. On 29-Aug-2025, significant information was received from consumer via contact center (MI No. NOV25-00697): The following Reporter updates were made: The primary reporter's city was updated. The postal code was updated The following patient demographics were updated: The patient's gender was updated to female.; Sender's Comments: This Female of an unspecified age experienced Viral infection after vaccination with COVID-19 Vaccine, Adjuvanted (2023-2024 Formula). The event Viral infection was reported as non-serious. Based on the spontaneous nature of the report, the causal relationship between COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) and Viral infection is considered Possible.
More
|
|||||||
| 2857456 | F | UT | 09/09/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Bell's palsy
Bell's palsy
|
Patient said she ended up with Bells Palsy after receiving vaccines; This is a spontaneous report re...
Patient said she ended up with Bells Palsy after receiving vaccines; This is a spontaneous report received from an Other HCP from a sales representative. An adult female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE NUMBER UNKNOWN, SINGLE; UNKNOWN MANUFACTURER), for COVID-19 immunization. The following information was reported: BELL'S PALSY (medically significant), outcome "unknown", described as "Patient said she ended up with Bells Palsy after receiving vaccines". It was unknown if therapeutic measures were taken as a result of bell's palsy. Clinical course: Patient said she ended up with Bells Palsy after receiving vaccines. Patient received any other vaccines on the same date as the vaccine was "Unknown". Patient received any other vaccines within 4 weeks prior to the vaccine was "Unknown". patient took any other medications within 2 weeks of the event starting was "Unknown". No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: A possible contributory role of the suspect products cannot be excluded for the reported event bells palsy based on the known safety profile The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators as appropriate.
More
|
|||||||
| 2857457 | 60 | F | MI | 09/09/2025 |
PNC20 |
PFIZER\WYETH |
|
Arthralgia
Arthralgia
|
my shoulder was hurting more than expected last night. It's doing better today; This is a spon...
my shoulder was hurting more than expected last night. It's doing better today; This is a spontaneous report received from a Consumer or other non HCP. A 60-year-old female patient (not pregnant) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 04Sep2025 as dose 1, single (Batch/Lot number: unknown) at the age of 60 years for immunisation. The patient's relevant medical history included: "cystic fibrosis related disorder" (unspecified if ongoing). Concomitant medication(s) included: IVACAFTOR; ALBUTEROL SULFATE. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 04Sep2025 at 14:00, outcome "recovering", described as "my shoulder was hurting more than expected last night. It's doing better today". Therapeutic measures were not taken as a result of vaccination site pain. Additional information: vaccine location reported as left shoulder. The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) will be requested and submitted if and when received.
More
|
||||||
| 2857458 | 78 | F | OR | 09/09/2025 |
COVID19 |
PFIZER\BIONTECH |
|
COVID-19, Vaccination failure
COVID-19, Vaccination failure
|
COVID-19 infection; COVID-19 infection; This is a spontaneous report received from a Consumer or oth...
COVID-19 infection; COVID-19 infection; This is a spontaneous report received from a Consumer or other non HCP,. A 78-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 06Aug2025 as dose 1, single (Batch/Lot number: unknown) at the age of 78 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE NUMBER UNKNOWN, SINGLE), for Covid-19 immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 infection". Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient stated that she have a prescription for Paxlovid. Toward the end of the call stated that patient got the Pfizer vaccines all around and patient just got a booster on 06Aug2025 and patient ended up getting it but patient guess that would going around. COVID after Pfizer Vaccines. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.
More
|
||||||
| 2857459 | PA | 09/09/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Cardiac disorder
Cardiac disorder
|
Heart Troubles; This is a spontaneous report received from a Consumer or other non HCP. A patient (...
Heart Troubles; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1), for COVID-19 immunisation. The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "Heart Troubles". Additional information: The patient have been having heart troubles since his/her second Pfizer covid vaccine shot. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.
More
|
||||||||
| 2857460 | 09/09/2025 |
COVID19 |
PFIZER\BIONTECH |
|
COVID-19, Drug ineffective
COVID-19, Drug ineffective
|
still got covid; still got covid; This is a spontaneous report received from a Consumer or other non...
still got covid; still got covid; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "still got covid". Clinical course: Reporter said she took all the covid vaccine but still got covid. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
More
|
|||||||||
| 2857461 | 09/09/2025 |
PNC20 |
PFIZER\WYETH |
|
Allergy to vaccine, Rash
Allergy to vaccine, Rash
|
allergy with Prevnar 20 Adult; This is a spontaneous report received from a Pharmacist, Program ID. ...
allergy with Prevnar 20 Adult; This is a spontaneous report received from a Pharmacist, Program ID. A patient (age and gender not provided) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG HYPERSENSITIVITY (non-serious), outcome "unknown", described as "allergy with Prevnar 20 Adult". Additional information: Product name reported as 'Prevnar 20 Adult'. Caller's Inquiry: Caller, a pharmacist is calling about a 'Prevnar 20 Adult' Allergy. They couldn't confirm what it was rather than a rush. Doesn't look anything severe but they have the same patient that they want to give the RSV vaccine to. HCP couldn't see anything that would be across the sensitivity of the medication. They would like to confirm if they are going to hold the RSV vaccine if there are patients who had allergy with Prevnar 20 Adult. The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) will be requested and submitted if and when received.
More
|
|||||||||
| 2857476 | 0.08 | M | FL | 09/09/2025 |
RV1 |
GLAXOSMITHKLINE BIOLOGICALS |
|
Haematochezia, Pyrexia
Haematochezia, Pyrexia
|
bloody stools for over 1 month, fever
bloody stools for over 1 month, fever
|
||||||
| 2857477 | 0.17 | F | CA | 09/09/2025 |
RV5 |
MERCK & CO. INC. |
Y015021 |
Diarrhoea, Gastrointestinal pathogen panel, Rotavirus test positive, Weight gain...
Diarrhoea, Gastrointestinal pathogen panel, Rotavirus test positive, Weight gain poor
More
|
Moderate diarrhea requiring 3 extra visits to our clinic, ER visit requiring IV hydration, weight ga...
Moderate diarrhea requiring 3 extra visits to our clinic, ER visit requiring IV hydration, weight gain deceleration
More
|
||||||
| 2857480 | M | PA | 09/09/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Inappropriate schedule of product administration
Inappropriate schedule of product administration
|
Inappropriate schedule of vaccine administered; This non-serious case was reported by a consumer via...
Inappropriate schedule of vaccine administered; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (First dose was received in SEP-2024). On 03-SEP-2025, the patient received the 2nd dose of Shingrix. On 03-SEP-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: Inappropriate schedule of vaccine administered). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt Date: 03-SEP-2025 The patient was scheduled to receive his second dose the morning of 3rd September 2025.
More
|
|||||||
| 2857481 | F | OH | 09/09/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
FT95N |
Fatigue, Product use in unapproved indication, Pyrexia
Fatigue, Product use in unapproved indication, Pyrexia
|
Fever; Fatigue; Shingrix first dose administration during an episode of Shingles; This non-serious c...
Fever; Fatigue; Shingrix first dose administration during an episode of Shingles; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of fever in an adult female patient who received Herpes zoster (Shingrix) (batch number FT95N, expiry date 25-APR-2027) for prophylaxis. Concurrent medical conditions included shingles. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fever (Verbatim: Fever), fatigue (Verbatim: Fatigue) and product use in unapproved indication (Verbatim: Shingrix first dose administration during an episode of Shingles). The outcome of the fever and fatigue were resolved and the outcome of the product use in unapproved indication was not applicable. It was unknown if the reporter considered the fever and fatigue to be related to Shingrix. It was unknown if the company considered the fever and fatigue to be related to Shingrix. Additional Information: GSK Receipt Date: 12-AUG-2025 A pharmacist wanted to get safety information related to the administration of the first dose of Shingrix during an episode of Herpes Zoster. The patient alerted the health care provider of this, 45 days after the vaccination and mentioned to have had fever and fatigue after its administration, claiming that she shouldn't have received the first dose.
More
|
|||||||
| 2857489 | 79 | F | NY | 09/09/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Somnolence
Somnolence
|
Sleepiness; This non-serious case was reported by a consumer via call center representative and desc...
Sleepiness; This non-serious case was reported by a consumer via call center representative and described the occurrence of sleepiness in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 29-MAY-2025, the patient received the 1st dose of Shingrix (intramuscular, left arm). On 29-MAY-2025, less than a day after receiving Shingrix, the patient experienced sleepiness (Verbatim: Sleepiness). On 30-MAY-2025, the outcome of the sleepiness was resolved (duration 24 hrs). It was unknown if the reporter considered the sleepiness to be related to Shingrix. It was unknown if the company considered the sleepiness to be related to Shingrix. Additional Information: GSK receipt date: 20-AUG-2025 Reporter and his wife both received their first dose and are scheduled for the second dose as PI recommends. Reporter stated that his wife was very sleepy the entire day.; Sender's Comments: US-GSK-US2025107983:same reporter
More
|
||||||
| 2857490 | F | 09/09/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Injection site reaction, Pain in extremity
Injection site reaction, Pain in extremity
|
a reaction around the injection site; a sore arm for 1-2 days; This non-serious case was reported b...
a reaction around the injection site; a sore arm for 1-2 days; This non-serious case was reported by a nurse via sales rep and described the occurrence of injection site reaction in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site reaction (Verbatim: a reaction around the injection site) and pain in arm (Verbatim: a sore arm for 1-2 days). The outcome of the injection site reaction was resolved and the outcome of the pain in arm was resolved (duration 2 days). It was unknown if the reporter considered the injection site reaction and pain in arm to be related to Shingrix. It was unknown if the company considered the injection site reaction and pain in arm to be related to Shingrix. Linked case(s) involving the same patient: US2025AMR111180 Additional Information: GSK Receipt Date: 22-AUG-2025 The patient got a reaction around the injection site and had a sore arm for 1-2 days, since she got dose 2 of Shingrix. The patient recovered and was glad she got the Shingrix vaccine. For the tolerance of the first dose please refer to the case US2025AMR111180.; Sender's Comments: US-GSK-US2025AMR111180:Shingrix dose 1
More
|
||||||||
| 2857491 | 86 | M | 09/09/2025 |
COVID19 |
MODERNA |
203F23A-1 |
Immunodeficiency, White blood cell count
Immunodeficiency, White blood cell count
|
unsure if his low immune system was pre-existing since they just started checking it a year ago; Thi...
unsure if his low immune system was pre-existing since they just started checking it a year ago; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) in an 86-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (batch no. 203F23A-1) for COVID-19 prophylaxis. Concurrent medical conditions included Chronic leukemia (x20 years) and Breathing difficult. On 02-Oct-2023, the patient received eighth dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (unknown route) .5 milliliter. On an unknown date, the patient experienced IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) (seriousness criterion medically significant). At the time of the report, IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, White blood cell count: white count being so high (over 100,000) for 20 years. No concomitant medication was reported. The patient received every Moderna vaccine that had come out since it was all started and the last one, he had was September 2024. Patient previously received Moderna vaccines on 01-Jan-2021 (lot#025L20A), 13-Jan-2021 (lot#025L20A), 10-Feb-2021 (lot#024M20A), 27-Sep-2021 (lot#041B21A), 07-Feb-2022 (lot#007J21-2A), 09-Sep-2022 (AS7140C) and 20-Apr-2023 (lot#065H22A). The patient's doctor told him he needed to get another COVID vaccine this year. His health problems - breathing problems and chronic leukemia were pre-existing before receiving the COVID vaccines but was unsure if his low immune system was preexisting since they just started checking it a year ago. The patient needed infusions to bring his hemoglobin and IgG back up every 3 months. The patient's most of the problems were on account of his chronic leukemia and his white count being so high (over 100,000) for 20 years. The patient was never had any ill effects from any of his vaccines. This case was linked to MOD-2025-789056 (Patient Link).; Reporter's Comments: Patients Chronic leukemia is a strong confounder for the event immunodeficiency. The benefit-risk relationship of product is not affected by this report.
More
|
|||||||
| 2857492 | 89 | M | 09/09/2025 |
COVID19 |
MODERNA |
3043156 |
Immunodeficiency, White blood cell count
Immunodeficiency, White blood cell count
|
unsure if his low immune system was pre-existing since they just started checking it a year ago; Thi...
unsure if his low immune system was pre-existing since they just started checking it a year ago; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) in an 89-year-old male patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3043156) for COVID-19 prophylaxis. Concurrent medical conditions included Breathing difficult and Chronic leukemia (x20 years). On 23-Sep-2024, the patient received ninth dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) .5 milliliter. On an unknown date, the patient experienced IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) (seriousness criterion medically significant). At the time of the report, IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, White blood cell count: white count being so high (over 100,000) for 20 years. No concomitant medication was reported. The patient received every Moderna vaccine that had come out since it was all started and the last one, he had was September 2024. Patient previously received Moderna vaccines on 01-Jan-2021 (lot#025L20A), 13-Jan-2021 (lot#025L20A), 10-Feb-2021 (lot#024M20A), 27-Sep-2021 (lot#041B21A), 07-Feb-2022 (lot#007J21-2A), 09-Sep-2022 (AS7140C), 20-Apr-2023 (lot#065H22A) and 02-Oct-2023 (lot#203F23A-1). The patient's doctor told him he needed to get another COVID vaccine this year. His health problems - breathing problems and chronic leukemia were pre-existing before receiving the COVID vaccines but was unsure if his low immune system was preexisting since they just started checking it a year ago. The patient needed infusions to bring his hemoglobin and IgG back up every 3 months. The patient's most of the problems were on account of his chronic leukemia and his white count being so high (over 100,000) for 20 years. The patient was never had any ill effects from any of his vaccines. This case was linked to MOD-2025-789056 (Patient Link).; Reporter's Comments: Patients Chronic leukemia is a strong confounder for the event immunodeficiency. The benefit-risk relationship of product is not affected by this report.
More
|
|||||||
| 2857559 | 34 | F | VA | 09/09/2025 |
FLU3 |
SANOFI PASTEUR |
u8823ca |
Injection site erythema, Injection site mass, Injection site pain, Injection sit...
Injection site erythema, Injection site mass, Injection site pain, Injection site swelling
More
|
Hard lump at injection site, with redness, tenderness and swelling, lasted over 24 hours
Hard lump at injection site, with redness, tenderness and swelling, lasted over 24 hours
|
||||||
| 2857560 | 67 | F | 09/09/2025 |
TYP |
BERNA BIOTECH, LTD. |
3004334 |
Urticaria
Urticaria
|
Broke out in hives. Hives were treated with Zyrtec and prednisone from patient's allergist and ...
Broke out in hives. Hives were treated with Zyrtec and prednisone from patient's allergist and resolved within a week.
More
|
|||||||
| 2857561 | 94 | M | IA | 09/09/2025 |
COVID19 |
MODERNA |
3032233 |
Death
Death
|
resident passed away
resident passed away
|
โ | |||||
| 2857562 | 30 | F | MI | 09/09/2025 |
HEPA |
GLAXOSMITHKLINE BIOLOGICALS |
MB599 |
Underdose, Wrong technique in product usage process
Underdose, Wrong technique in product usage process
|
Client was administered a Pediatric dose of Hep A instead of an Adult dose of Hep A. When error not...
Client was administered a Pediatric dose of Hep A instead of an Adult dose of Hep A. When error noted the client was brought back into immunization room (during same visit), situation explained to client, who was agreeable to receiving #2 Pediatric Hep A dose and was then administered #2 Pediatric dose Hep A to equal the Adult dose of Hep A. Prior to receiving #2 dose nurse brought both Pediatric Hep A and Adult Hep A boxes in to show client. The Pediatric dose is: 720ELU/0.5ml and Adult dose is: 1440 ELU/ml. Medical director was notified of event. Client did waiting period post vaccination in clinic lobby for 10-15 minutes and denied any difficulties/discomforts prior to exiting health department building, ambulating without difficulty.
More
|
||||||
| 2857563 | 39 | F | NY | 09/09/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
078C2IA 004F21A |
Fatigue, Feeling hot, Hyperhidrosis, Immediate post-injection reaction, Vomiting...
Fatigue, Feeling hot, Hyperhidrosis, Immediate post-injection reaction, Vomiting; Fatigue, Feeling hot, Hyperhidrosis, Immediate post-injection reaction, Vomiting
More
|
After my 2nd shot I had an immediate reaction of hot sweats, vomit and extreme exhaustion. I have pr...
After my 2nd shot I had an immediate reaction of hot sweats, vomit and extreme exhaustion. I have proof of that experience.
More
|
โ | โ | โ | |||
| 2857564 | 43 | M | AK | 09/09/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
040C21A 048F21A |
Biopsy thyroid gland, Thyroid mass, Ultrasound thyroid abnormal; Biopsy thyroid ...
Biopsy thyroid gland, Thyroid mass, Ultrasound thyroid abnormal; Biopsy thyroid gland, Thyroid mass, Ultrasound thyroid abnormal
More
|
After shot I noticed lumps on my thyroid as they grew I went to the facility where they did ultrasou...
After shot I noticed lumps on my thyroid as they grew I went to the facility where they did ultrasound and biopsy.
More
|
||||||
| 2857565 | 0.42 | M | FL | 09/09/2025 |
PNC20 |
PFIZER\WYETH |
LK6653 |
Incorrect route of product administration, No adverse event
Incorrect route of product administration, No adverse event
|
Vaccine route should've been intramuscular but inadvertently given orally instead. Patient exa...
Vaccine route should've been intramuscular but inadvertently given orally instead. Patient examined by doctor and parents were instructed to return to clinic that same afternoon then again, the following morning with no adverse reactions noted at any time.
More
|
||||||
| 2857566 | 65 | F | KY | 09/09/2025 |
COVID19 FLU3 |
MODERNA SEQIRUS, INC. |
3052663 407242 |
Erythema, Peripheral swelling, Pruritus; Erythema, Peripheral swelling, Pruritus
Erythema, Peripheral swelling, Pruritus; Erythema, Peripheral swelling, Pruritus
|
Patient states in the arm she received her Spikevax vaccine (right arm) she experienced a raised red...
Patient states in the arm she received her Spikevax vaccine (right arm) she experienced a raised red, itchy, bump about 1-2 inches in diameter. It started about 8 hours after receiving the vaccine. Overnight the swelling went down some and has improved so far as of 10am day after administration. Patient does not seem concerned about her safety but reported just to be sure. We are reporting patient recovered field as unknown since it's not gone away completely but it is improving.
More
|
||||||
| 2857568 | 38 | F | MO | 09/09/2025 |
VARCEL |
MERCK & CO. INC. |
|
No adverse event, Wrong product administered
No adverse event, Wrong product administered
|
She did not need to receive the Varicella vaccine. Her Varicella Antibody was positive indicating im...
She did not need to receive the Varicella vaccine. Her Varicella Antibody was positive indicating immunity. Varicella was inadvertently administered during date of hire appointment. No adverse reactions reported. She only questioned on 9/8/25 why Varicella was administered on 9/2/25.
More
|
||||||
| 2857569 | 22 | M | WI | 09/09/2025 |
MMR |
MERCK & CO. INC. |
Z002520 |
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
Pt was administered dose of MMR, when was fully vaccinated to MMR based on immunization records. Pt ...
Pt was administered dose of MMR, when was fully vaccinated to MMR based on immunization records. Pt has not reported any issues or symptoms.
More
|
||||||
| 2857570 | 18 | F | KY | 09/09/2025 |
FLU3 |
SEQIRUS, INC. |
|
Dizziness, Syncope
Dizziness, Syncope
|
Two minutes after administering the shot, the patient felt dizzy and fainted for few seconds.
Two minutes after administering the shot, the patient felt dizzy and fainted for few seconds.
|
||||||
| 2857571 | 2 | F | KY | 09/09/2025 |
DTAPIPV |
GLAXOSMITHKLINE BIOLOGICALS |
y49bz |
Product administered to patient of inappropriate age, Wrong patient received pro...
Product administered to patient of inappropriate age, Wrong patient received product
More
|
Both siblings in the room, both receiving vaccines. Nurse asked for 5 year old sister, parents place...
Both siblings in the room, both receiving vaccines. Nurse asked for 5 year old sister, parents placed the 2 year old child on the exam table for vaccinations. Vaccinations were administered. Next nurse came in to give 2 year old sister vaccines and seen the bandaids. At this time it was realized that the vaccines for the 5 year old were given to the 2 year old. (all vaccines were correct except the Kinrix)
More
|
||||||
| 2857572 | 79 | M | IA | 09/09/2025 |
COVID19 |
MODERNA |
3046731 |
Death
Death
|
Resident passed away
Resident passed away
|
โ | |||||
| 2857573 | 67 | F | TX | 09/09/2025 |
UNK UNK |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
|
Asthenia, Cough, Dizziness, Dyspepsia, Headache; Malaise, Nausea, Pyrexia
Asthenia, Cough, Dizziness, Dyspepsia, Headache; Malaise, Nausea, Pyrexia
|
next morning woke up with a cough that lasted about 30 minutes with a fever, headache, dizziness, na...
next morning woke up with a cough that lasted about 30 minutes with a fever, headache, dizziness, nausea, and weakness. As the week went on she also developed severe heartburn when attempting to eating anything even though she already takes daily medicine for it. She feels very unwell and continues to have these symptoms for a week with no improvement. Will follow up with her physician.
More
|
||||||
| 2857574 | 0.33 | M | PA | 09/09/2025 |
DTAPHEPBIP HIBV PNC20 RSV RV1 |
GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR PFIZER\WYETH PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
|
Ear infection, Electroencephalogram, Infantile spasms; Ear infection, Electroenc...
Ear infection, Electroencephalogram, Infantile spasms; Ear infection, Electroencephalogram, Infantile spasms; Ear infection, Electroencephalogram, Infantile spasms; Ear infection, Electroencephalogram, Infantile spasms; Ear infection, Electroencephalogram, Infantile spasms
More
|
Vaccines received on 10/2/2024, prescribed amoxicillin-clavulanate (Augmentin ES-600) for an ear in...
Vaccines received on 10/2/2024, prescribed amoxicillin-clavulanate (Augmentin ES-600) for an ear infection on 10/25/2024, and diagnosed with infantile spasms on 11/07/2024. He may have been having spasms prior to 11/07 that were missed.
More
|
โ | |||||
| 2857575 | 64 | M | FL | 09/09/2025 |
FLU3 |
SANOFI PASTEUR |
u8790aa |
Myalgia, Pain
Myalgia, Pain
|
Patient felt muscle paint and soreness over a week after the vaccine
Patient felt muscle paint and soreness over a week after the vaccine
|
||||||
| 2857576 | 90 | F | MD | 09/09/2025 |
FLU3 FLU3 |
SANOFI PASTEUR SANOFI PASTEUR |
U8800DA U8800DA |
Anaemia, Blood alkaline phosphatase increased, Chills, Chronic kidney disease, G...
Anaemia, Blood alkaline phosphatase increased, Chills, Chronic kidney disease, Glomerular filtration rate decreased; Hypotension, Influenza virus test negative, Respiratory syncytial virus test negative, SARS-CoV-2 test negative, Vomiting
More
|
Severe hypotension (69/34) with 2 episodes of vomiting and chills a few hours after vaccination requ...
Severe hypotension (69/34) with 2 episodes of vomiting and chills a few hours after vaccination requiring
More
|
โ | |||||
| 2857577 | 42 | F | CO | 09/09/2025 |
COVID19 |
PFIZER\BIONTECH |
Na |
Condition aggravated, Epilepsy
Condition aggravated, Epilepsy
|
The vaccines caused or exacerbated my epilepsy
The vaccines caused or exacerbated my epilepsy
|
||||||
| 2857578 | 5 | M | ME | 09/09/2025 |
DTAPIPV MMRV |
GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. |
Y49BZ Z009075 |
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
Patient received an extra dose of Dtap/IPV and MMRV because documentation from previous PCP was not ...
Patient received an extra dose of Dtap/IPV and MMRV because documentation from previous PCP was not received. Family aware, child is asymptomatic.
More
|
||||||
| 2857579 | 15 | M | IA | 09/09/2025 |
MNQ TDAP |
NOVARTIS VACCINES AND DIAGNOSTICS GLAXOSMITHKLINE BIOLOGICALS |
X4T99 25A2F |
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
No adverse event was noted. This was given in error as the person already had these vaccines in 2022...
No adverse event was noted. This was given in error as the person already had these vaccines in 2022.
More
|
||||||
| 2857580 | 65 | F | MI | 09/09/2025 |
PNC21 |
MERCK & CO. INC. |
|
Injection site erythema, Injection site pain, Injection site pruritus, Injection...
Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site urticaria
More
|
Redness, swelling, soreness, itching, hives at injection site lasting 2 weeks. Area of redness a...
Redness, swelling, soreness, itching, hives at injection site lasting 2 weeks. Area of redness and swelling approx 6? in diameter. Looked like cellulitis.
More
|
||||||
| 2857581 | 16 | F | IA | 09/09/2025 |
FLU3 |
SANOFI PASTEUR |
UT8794BA |
Incorrect dose administered
Incorrect dose administered
|
High dose influenza accidentally given instead of regular flu dose.
High dose influenza accidentally given instead of regular flu dose.
|
||||||
| 2857582 | 11 | F | NJ | 09/09/2025 |
HPV9 HPV9 |
MERCK & CO. INC. MERCK & CO. INC. |
|
Heavy menstrual bleeding, Laboratory test, Menstruation irregular, Migraine, Pai...
Heavy menstrual bleeding, Laboratory test, Menstruation irregular, Migraine, Pain; Tremor
More
|
Body shakes, migraines, irregular very heavy periods, tremors, none aches
Body shakes, migraines, irregular very heavy periods, tremors, none aches
|
โ | โ | ||||
| 2857583 | 16 | M | PA | 09/09/2025 |
HEP IPV MMR MNQ TDAP VARCEL |
GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. |
GC3N4 X1D141M N3429 U8361AA LX494 Y011019 |
Extra dose administered; Extra dose administered; Extra dose administered; Extra...
Extra dose administered; Extra dose administered; Extra dose administered; Extra dose administered; Extra dose administered; Extra dose administered
More
|
Student and older sister (21years old) came to get vaccinated. Student brought in his immigration v...
Student and older sister (21years old) came to get vaccinated. Student brought in his immigration vaccine records only. Asked multiple times if they had other records and sister said no. Someone else was also checked after student was vaccinated sister then said student was just vaccinated a few weeks ago and showed records
More
|
||||||
| 2857584 | 0.75 | F | CO | 09/09/2025 |
HIBV IPV PNC20 TDAP |
SANOFI PASTEUR SANOFI PASTEUR PFIZER\WYETH SANOFI PASTEUR |
UK328AA Y1A212M MF0415 U8564AA |
Wrong product administered; Wrong product administered; Wrong product administer...
Wrong product administered; Wrong product administered; Wrong product administered; Wrong product administered
More
|
Administered Tdap, as opposed to DTaP, improper dosage
Administered Tdap, as opposed to DTaP, improper dosage
|
||||||
| 2857585 | 16 | F | IL | 09/09/2025 |
MENB MNQ |
PFIZER\WYETH SANOFI PASTEUR |
GX1463 U8193AB |
Arthralgia, Injected limb mobility decreased, Magnetic resonance imaging abnorma...
Arthralgia, Injected limb mobility decreased, Magnetic resonance imaging abnormal, Tendonitis; Arthralgia, Injected limb mobility decreased, Magnetic resonance imaging abnormal, Tendonitis
More
|
Vaccine was given 8/16/24. Mom called our office 12/11/24 and said that she has been having left sho...
Vaccine was given 8/16/24. Mom called our office 12/11/24 and said that she has been having left shoulder pain since the injection was given. She was seen in our office 12/20/24 and states that she had intermittent pain and range of motion of L shoulder. She was referred to an orthopedic specialist who she has seen in January 2025, July 2025, September 2025. She has tried physical therapy. She has undergone an MRI and is scheduled for MRI arthrogram
More
|
โ | |||||
| 2857586 | 1.25 | F | IN | 09/09/2025 |
DTAP HIBV PNC20 |
GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR PFIZER\WYETH |
5KR3R UK151AA LN4928 |
Injection site urticaria; Injection site urticaria; Injection site urticaria
Injection site urticaria; Injection site urticaria; Injection site urticaria
|
Patient developed large, red, raised, irregular, wheals in the evening of 09/05/2025 at injection si...
Patient developed large, red, raised, irregular, wheals in the evening of 09/05/2025 at injection sites bilaterally after receiving vaccines on 09/03/2025. Right site's wheal approx. 9 cm in length and width; left site's wheal approx. 7 cm in length and width. Patient's parent applied hydrocortisone cream topically to sites bilaterally before bedtime. Wheals were improved upon waking on 09/06/2025, with only slight erythema remaining measuring approx. 5 cm in diameter around injection sites bilaterally. Patient seen in office in morning of 09/06/2025.
More
|
||||||
| 2857587 | 1.67 | M | IA | 09/09/2025 |
DTAP |
GLAXOSMITHKLINE BIOLOGICALS |
|
Dyspnoea, Erythema, Urticaria
Dyspnoea, Erythema, Urticaria
|
5 days later 4 spots appeared, 7 days later full body covered in red welts. On the 8th day continues...
5 days later 4 spots appeared, 7 days later full body covered in red welts. On the 8th day continues to get worse and has labored breathing.
More
|